VKTX
NASDAQ HealthcareViking Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $35.47 |
|---|---|
| Volume | 2,133,047 |
| Market Cap | 4.10B |
| Beta | 0.790 |
| RSI (14-Day) | 67.0 |
| 200-Day MA | $31.77 |
| 50-Day MA | $31.94 |
| 52-Week High | $43.15 |
| 52-Week Low | $18.92 |
| Forward P/E | -7.76 |
| Price / Book | 6.37 |
🎯 Investment Strategy Scores
How VKTX scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
38/100
High dividend yield + low volatility
🚀 Moon Shot
17/100
High growth potential (high beta + oversold)
🔪 Falling Knife
12/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
92/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
56/100
Large-cap, institutional-quality stocks
Find VKTX in your text
Paste any text on the homepage — the tool will extract VKTX and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.